S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
Silicon Motion Proves That AI in Motion Stays in Motion
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
Silicon Motion Proves That AI in Motion Stays in Motion
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
Silicon Motion Proves That AI in Motion Stays in Motion
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
Silicon Motion Proves That AI in Motion Stays in Motion
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities

Ikena Oncology (IKNA) SEC Filings & 10K Form

$1.27
-0.01 (-0.78%)
(As of 04/16/2024 ET)

Recent Ikena Oncology SEC Filings

DateFilerForm TypeView
03/12/2024
6:48 AM
Ikena Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2024
6:30 AM
Ikena Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2024
7:19 AM
FMR LLC (Filed by)
Ikena Oncology (Subject)
Form SC 13G/A
02/21/2024
3:29 PM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:57 PM
CITADEL ADVISORS LLC (Filed by)
Ikena Oncology (Subject)
Form SC 13G/A
02/14/2024
8:47 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Ikena Oncology (Subject)
Form SC 13G/A
02/09/2024
8:16 AM
Ikena Oncology (Subject)
Form SC 13G/A
02/02/2024
4:15 PM
Ecsedy Jeffrey (Reporting)
Ikena Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:07 PM
Ikena Oncology (Issuer)
Manfredi Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:08 PM
Ikena Oncology (Issuer)
Marango Jotin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:26 PM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:09 AM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:30 AM
Ikena Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/19/2023
2:33 PM
GILEAD SCIENCES, INC. (Filed by)
Ikena Oncology (Subject)
Form SC 13G
10/11/2023
4:10 PM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2023
3:05 PM
Ikena Oncology (Filer)
Form DEF 14A
09/21/2023
4:02 PM
Ikena Oncology (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
Form 4/A
09/21/2023
4:04 PM
Bonita David P (Reporting)
Ikena Oncology (Issuer)
Form 4/A
09/21/2023
3:52 PM
Ikena Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
09/15/2023
3:05 PM
Ikena Oncology (Filer)
Form PRE 14A
09/14/2023
8:22 PM
Ikena Oncology (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
8:17 PM
Bonita David P (Reporting)
Ikena Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
3:21 PM
Ikena Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
09/12/2023
3:11 PM
Ikena Oncology (Filer)
Form 424B5
09/10/2023
11:15 PM
Ikena Oncology (Filer)
Form EFFECT
08/10/2023
6:00 AM
Ikena Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2023
7:02 AM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2023
4:15 PM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2023
3:30 PM
FORMELA JEAN FRANCOIS (Reporting)
Ikena Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:30 PM
Ikena Oncology (Issuer)
Wooster Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:30 PM
Bonita David P (Reporting)
Ikena Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:30 PM
Ikena Oncology (Issuer)
Koehler Maria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:30 PM
Ikena Oncology (Issuer)
Stampacchia Otello (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:30 PM
Hughes Owen (Reporting)
Ikena Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:30 PM
Dukes Iain D. (Reporting)
Ikena Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
8:09 AM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
6:27 AM
Ikena Oncology (Filer)
Form 424B5
05/15/2023
5:04 AM
Ikena Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2023
7:17 AM
Ikena Oncology (Filer)
Form DEF 14A
04/28/2023
7:20 AM
Ikena Oncology (Filer)
Form DEFA14A
04/28/2023
7:24 AM
Ikena Oncology (Filer)
Form ARS
Can't believe it's happening again (Ad)

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.
04/17/2023
8:14 AM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:IKNA) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners